These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 9706048)
1. In vivo properties of an in situ forming gel for parenteral delivery of macromolecular drugs. Joshi R; Arora V; Desjardins JP; Robinson D; Himmelstein KJ; Iversen PL Pharm Res; 1998 Aug; 15(8):1189-95. PubMed ID: 9706048 [TBL] [Abstract][Full Text] [Related]
2. In vitro properties of an in situ forming gel for the parenteral delivery of macromolecular drugs. Joshi R; Robinson DH; Himmelstein KJ Pharm Dev Technol; 1999; 4(4):515-22. PubMed ID: 10578505 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of the rat cytochrome P450 3A2 by an antisense phosphorothioate oligodeoxynucleotide in vivo. Desjardins JP; Iversen PL J Pharmacol Exp Ther; 1995 Dec; 275(3):1608-13. PubMed ID: 8531135 [TBL] [Abstract][Full Text] [Related]
4. Biodegradable in situ gel-forming controlled drug delivery system based on thermosensitive PCL-PEG-PCL hydrogel. Part 2: sol-gel-sol transition and drug delivery behavior. Gong C; Shi S; Wu L; Gou M; Yin Q; Guo Q; Dong P; Zhang F; Luo F; Zhao X; Wei Y; Qian Z Acta Biomater; 2009 Nov; 5(9):3358-70. PubMed ID: 19470411 [TBL] [Abstract][Full Text] [Related]
5. In situ gel formulations for gene delivery: release and myotoxicity studies. Ismail FA; Napaporn J; Hughes JA; Brazeau GA Pharm Dev Technol; 2000; 5(3):391-7. PubMed ID: 10934739 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evaluation of an in situ gel forming system for the delivery of PEGylated octreotide. Erfani Jabarian L; Rouini MR; Atyabi F; Foroumadi A; Nassiri SM; Dinarvand R Eur J Pharm Sci; 2013 Jan; 48(1-2):87-96. PubMed ID: 23131800 [TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo release of albumin using a biodegradable MPEG-PCL diblock copolymer as an in situ gel-forming carrier. Hyun H; Kim YH; Song IB; Lee JW; Kim MS; Khang G; Park K; Lee HB Biomacromolecules; 2007 Apr; 8(4):1093-100. PubMed ID: 17326678 [TBL] [Abstract][Full Text] [Related]
8. Poloxamer-based in situ hydrogels for controlled delivery of hydrophilic macromolecules after intramuscular injection in rats. Zhang K; Shi X; Lin X; Yao C; Shen L; Feng Y Drug Deliv; 2015 May; 22(3):375-82. PubMed ID: 24601854 [TBL] [Abstract][Full Text] [Related]
9. A pH- and temperature-responsive bioresorbable injectable hydrogel based on polypeptide block copolymers for the sustained delivery of proteins in vivo. Turabee MH; Thambi T; Duong HTT; Jeong JH; Lee DS Biomater Sci; 2018 Feb; 6(3):661-671. PubMed ID: 29423489 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization and evaluation of tinidazole-loaded mPEG-PDLLA (10/90) in situ gel forming system for periodontitis treatment. Tian Y; Shen Y; Jv M Drug Deliv; 2016 Oct; 23(8):2726-2735. PubMed ID: 26289210 [TBL] [Abstract][Full Text] [Related]
11. Transdermal delivery of antisense oligonucleotides can induce changes in gene expression in vivo. Brand RM; Hannah TL; Norris J; Iversen PL Antisense Nucleic Acid Drug Dev; 2001 Feb; 11(1):1-6. PubMed ID: 11258617 [TBL] [Abstract][Full Text] [Related]
12. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition. Kwon YM; Kim SW Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317 [TBL] [Abstract][Full Text] [Related]
13. Thermosensitive PEG-PCL-PEG (PECE) hydrogel as an in situ gelling system for ocular drug delivery of diclofenac sodium. Luo Z; Jin L; Xu L; Zhang ZL; Yu J; Shi S; Li X; Chen H Drug Deliv; 2016; 23(1):63-8. PubMed ID: 24758189 [TBL] [Abstract][Full Text] [Related]
14. In vivo osteogenic differentiation of rat bone marrow stromal cells in thermosensitive MPEG-PCL diblock copolymer gels. Kim MS; Kim SK; Kim SH; Hyun H; Khang G; Lee HB Tissue Eng; 2006 Oct; 12(10):2863-73. PubMed ID: 17518655 [TBL] [Abstract][Full Text] [Related]
15. Development, characterization and application of in situ gel systems for intranasal delivery of tacrine. Qian S; Wong YC; Zuo Z Int J Pharm; 2014 Jul; 468(1-2):272-82. PubMed ID: 24709220 [TBL] [Abstract][Full Text] [Related]
16. PEG-PLGA based large porous particles for pulmonary delivery of a highly soluble drug, low molecular weight heparin. Patel B; Gupta V; Ahsan F J Control Release; 2012 Sep; 162(2):310-20. PubMed ID: 22800582 [TBL] [Abstract][Full Text] [Related]
17. In situ phase transition of microemulsions for parenteral injection yielding lyotropic liquid crystalline carriers of the antitumor drug bufalin. Li Y; Angelova A; Liu J; Garamus VM; Li N; Drechsler M; Gong Y; Zou A Colloids Surf B Biointerfaces; 2019 Jan; 173():217-225. PubMed ID: 30296646 [TBL] [Abstract][Full Text] [Related]
18. In situ gelling polyvalerolactone-based thermosensitive hydrogel for sustained drug delivery. Mishra GP; Kinser R; Wierzbicki IH; Alany RG; Alani AW Eur J Pharm Biopharm; 2014 Oct; 88(2):397-405. PubMed ID: 24931340 [TBL] [Abstract][Full Text] [Related]
19. Thermosensitive in situ nanogel as ophthalmic delivery system of curcumin: development, characterization, in vitro permeation and in vivo pharmacokinetic studies. Liu R; Sun L; Fang S; Wang S; Chen J; Xiao X; Liu C Pharm Dev Technol; 2016 Aug; 21(5):576-82. PubMed ID: 26024239 [TBL] [Abstract][Full Text] [Related]
20. Local, Controlled Delivery of Local Anesthetics In Vivo from Polymer - Xerogel Composites. Qu H; Costache MC; Inan S; Cowan A; Devore D; Ducheyne P Pharm Res; 2016 Mar; 33(3):729-38. PubMed ID: 26555665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]